About Us
Our Mission & Values
Leadership Team
Board of Directors
Partners
Corporate Giving
Responsibility
Press Releases
Medicines
Science
Clinical Trials
Publications
Treatment Access
Patients & Caregivers
Our Commitment to Patients
Patient Voices
CKD with Hyperphosphatemia
IBS-C
Join Us
Working at Ardelyx
Benefits
Open Positions
Medical Professionals
Investors & Media
About Us
Our Mission & Values
Leadership Team
Board of Directors
Partners
Corporate Giving
Responsibility
Press Releases
Medicines
Science
Clinical Trials
Publications
Treatment Access
Patients & Caregivers
Our Commitment to Patients
Patient Voices
CKD with Hyperphosphatemia
IBS-C
Join Us
Working at Ardelyx
Benefits
Open Positions
Medical Professionals
Investors & Media
Publications
Disease Area
Hyperphosphatemia
IBS-C
Year
All
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015
2014
Filter
Safety and Efficacy of Tenapanor for Long-term Serum Phosphate Control in Maintenance Dialysis: A 52-Week Randomized Phase 3 Trial (PHREEDOM)
Kidney360
Phosphate Control: The Next Frontier in Dialysis Cardiovascular Mortality
Cardiorenal Medicine
Small Intestinal Phosphate Absorption: Novel Therapeutic Implications
American Journal of Nephrology
Phosphate Balance and CKD–Mineral Bone Disease
Kidney International Reports
How to Evaluate Phosphate Control in Patients on Dialysis
Nephrology Dialysis Transplantation
Pages:
1
2
3
4
5
6
7
8
Load More
Sorry, nothing found in this query